TY - JOUR
T1 - A "Three-Plus-One" Evaluation Model for Clinical Research Management
AU - Dilts, David M.
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contributions of David M. Dilts are supported by The National Cancer Institute (NCI) of the National Institutes of Health (NIH), Contract SAIC-F Agreement 13XS141 and Oregon Clinical & Translational Research Institute (OCTRI), Grant Number (UL1TR000128 from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The content of the article is the sole responsibility of the author and does not necessarily represent the official views of the NIH.
PY - 2013/12
Y1 - 2013/12
N2 - Clinical research management (CRM) is a critical resource for the management of clinical trials and it requires proper evaluation. This article advances a model of evaluation that has three local levels, plus one global level, for evaluating the value of CRM. The primary level for evaluation is that of the study or processes level. The managerial or aggregate level concerns management of the portfolio of trials under the control of the CRM office. The third, often overlooked level of evaluation, is the strategic level, whose goal is encapsulated in the phrase, "doing the right trials, while doing trials right." The global ("plus one") evaluation level concerns the need to evaluate the ever-increasing number of multi-institutional and multinational studies. As there are host of evaluation metrics, this article provides representative examples of metrics at each level and provides methods that can aid in the selecting appropriate metrics for an organization.
AB - Clinical research management (CRM) is a critical resource for the management of clinical trials and it requires proper evaluation. This article advances a model of evaluation that has three local levels, plus one global level, for evaluating the value of CRM. The primary level for evaluation is that of the study or processes level. The managerial or aggregate level concerns management of the portfolio of trials under the control of the CRM office. The third, often overlooked level of evaluation, is the strategic level, whose goal is encapsulated in the phrase, "doing the right trials, while doing trials right." The global ("plus one") evaluation level concerns the need to evaluate the ever-increasing number of multi-institutional and multinational studies. As there are host of evaluation metrics, this article provides representative examples of metrics at each level and provides methods that can aid in the selecting appropriate metrics for an organization.
KW - CRM value
KW - global evaluation
KW - managerial evaluation
KW - strategic evaluation
UR - http://www.scopus.com/inward/record.url?scp=84887430039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887430039&partnerID=8YFLogxK
U2 - 10.1177/0163278713499019
DO - 10.1177/0163278713499019
M3 - Article
C2 - 23908383
AN - SCOPUS:84887430039
SN - 0163-2787
VL - 36
SP - 464
EP - 477
JO - Evaluation and the Health Professions
JF - Evaluation and the Health Professions
IS - 4
ER -